peroxynitrous acid has been researched along with Parkinson Disease in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (56.52) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, C; Li, L; Li, Z; Lim, K; Liu, Z; Shaibani, MSS; Sun, Q; Xu, J; Zhang, C | 1 |
| Lerner, A; McCarty, MF | 1 |
| Garcia-Buendia, J; Muñoz, FJ; Picón-Pagès, P | 1 |
| Di Monte, DA; Drescher, M; Gerding, HR; Karreman, C; Lashuel, HA; Leist, M; Outeiro, TF; Schildknecht, S | 1 |
| Abdollahi, M; Akhondzadeh, S; Faramarzi, MA; Ghaeli, P; Javadi, MR; Kouti, L; Mousavi, S; Noroozian, M | 1 |
| Hao, MW; Hu, ZT; Qin, XL; Sun, L; Zhang, QS | 1 |
| McCarty, MF | 1 |
| Corbett, J; Kadiiska, MB; Kumar, A; Leinisch, F; Mason, RP | 1 |
| Andersen, JK; Chinta, SJ | 2 |
| Bharath, MM; Dubey, SK; Harish, G; Misra, K; Mythri, RB | 1 |
| Cadenas, E; Dias, LC; Rettori, D; Tang, Y | 1 |
| Ebadi, M; Sharma, SK | 1 |
| Borutaite, V; Brown, GC | 1 |
| Giasson, BI; Hodara, R; Ischiropoulos, H; Lee, VM; Lynch, DR; Mishizen-Eberz, AJ; Norris, EH; Trojanowski, JQ | 1 |
| Brown-Borg, H; Ebadi, M; El Refaey, H; Ghafourifar, P; Sharma, SK | 1 |
| Combs, CK; Ebadi, M; Shavali, S | 1 |
| Dahm, CC; Moore, K; Murphy, MP | 1 |
| Abe, T; Isobe, C; Kikuchi, T; Murata, T; Sato, C; Terayama, Y | 1 |
| Angeloni, C; Ravaioli, G; Rodriguez-Mateos, A; Spencer, JP; Vafeiadou, K; Vauzour, D | 1 |
| Boveris, AD; Cadenas, E; Poderoso, JJ; Riobó, NA; Schöpfer, FJ | 1 |
| Carvey, PM; Gayle, DA; Landers, T; Ling, Z; Lipton, JW; Tong, C | 1 |
| Iravani, MM; Jenner, P; Kashefi, K; Mander, P; Rose, S | 1 |
6 review(s) available for peroxynitrous acid and Parkinson Disease
| Article | Year |
|---|---|
Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson's Disease.
Topics: Animals; Dietary Supplements; Free Radical Scavengers; Humans; Parkinson Disease; Peroxynitrous Acid; Plant Extracts | 2020 |
Functions and dysfunctions of nitric oxide in brain.
Topics: Alzheimer Disease; Animals; Brain; Humans; Nitric Oxide; Nitrosative Stress; Oxidative Stress; Parkinson Disease; Peroxynitrous Acid; Protein Processing, Post-Translational; Proteins | 2019 |
Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies.
Topics: alpha-Synuclein; Humans; Nerve Degeneration; Nitric Oxide; Oxidative Stress; Parkinson Disease; Peroxynitrous Acid | 2013 |
Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease.
Topics: Electron Transport Complex I; Humans; Mitochondria; Nitric Oxide; Oxidative Stress; Parkinson Disease; Peroxynitrous Acid; Reactive Nitrogen Species | 2011 |
Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Deoxyguanosine; DNA Fragmentation; Dopamine; Free Radicals; Humans; Mitochondria; Nerve Tissue Proteins; Neurons; Neurotoxins; Nitric Oxide; Nitric Oxide Synthase; Parkinson Disease; Peroxynitrous Acid; Synucleins | 2003 |
Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols.
Topics: Adenosine Triphosphate; Animals; Electron Transport Complex I; Humans; Iron-Sulfur Proteins; Macrophages; Mitochondria; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrosation; Nitroso Compounds; Parkinson Disease; Peroxynitrous Acid; Reactive Nitrogen Species; Tyrosine | 2004 |
17 other study(ies) available for peroxynitrous acid and Parkinson Disease
| Article | Year |
|---|---|
Ultrafast Detection of Peroxynitrite in Parkinson's Disease Models Using a Near-Infrared Fluorescent Probe.
Topics: Animals; Brain; Caenorhabditis elegans; Disease Models, Animal; Fluorescent Dyes; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Parkinson Disease; PC12 Cells; Peroxynitrous Acid; Rats | 2020 |
Nitric oxide and peroxynitrite serum levels in Parkinson's disease: correlation of oxidative stress and the severity of the disease.
Topics: Aged; Case-Control Studies; Female; Humans; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Parkinson Disease; Peroxynitrous Acid; Severity of Illness Index | 2013 |
Lower Serum Bilirubin and Uric Acid Concentrations in Patients with Parkinson's Disease in China.
Topics: Aged; Aged, 80 and over; Antioxidants; Asian People; Bilirubin; Case-Control Studies; China; Dopamine; Dose-Response Relationship, Drug; Female; Free Radicals; Humans; Male; Middle Aged; Oxidative Stress; Parkinson Disease; Peroxynitrous Acid; Substantia Nigra; Uric Acid | 2015 |
Potential ghrelin-mediated benefits and risks of hydrogen water.
Topics: Animals; Antioxidants; Free Radical Scavengers; Gastric Mucosa; Ghrelin; Hydrogen; Mice; Parkinson Disease; Peroxynitrous Acid; Stomach; Water | 2015 |
Formation and Implications of Alpha-Synuclein Radical in Maneb- and Paraquat-Induced Models of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Cyclic N-Oxides; Disease Models, Animal; Dopaminergic Neurons; Injections, Intraperitoneal; Male; Maneb; Mesencephalon; Mice, Inbred C57BL; Microglia; Models, Biological; NADPH Oxidases; Nitric Oxide Synthase Type II; Paraquat; Parkinson Disease; Peroxynitrous Acid; Spin Labels; Substantia Nigra; Tyrosine 3-Monooxygenase | 2016 |
Glutamoyl diester of the dietary polyphenol curcumin offers improved protection against peroxynitrite-mediated nitrosative stress and damage of brain mitochondria in vitro: implications for Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Brain; Curcumin; Diet; Electron Transport Complex I; Esters; Flavonoids; Glutamates; Mice; Mitochondria; Mitochondrial Proteins; Mitochondrial Swelling; Parkinson Disease; Peroxynitrous Acid; Phenols; Polyphenols; Protective Agents; Tyrosine | 2011 |
Pathways of dopamine oxidation mediated by nitric oxide.
Topics: Dopamine; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Hydrogen-Ion Concentration; Magnetics; Models, Chemical; Nitric Oxide; Oxygen; Parkinson Disease; Peroxynitrous Acid; Time Factors | 2002 |
Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.
Topics: alpha-Synuclein; Calpain; Chymotrypsin; Humans; Hydrolysis; Microscopy, Immunoelectron; Nerve Degeneration; Nerve Tissue Proteins; Nitrates; Parkinson Disease; Peptide Fragments; Peroxynitrous Acid; Recombinant Proteins; Solubility; Synucleins; Tyrosine | 2005 |
Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins.
Topics: Animals; Cell Line; DNA, Complementary; Glutathione; Humans; Metallothionein; Mice; Microscopy, Fluorescence; Neuroprotective Agents; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Parkinson Disease; Peroxynitrous Acid | 2005 |
Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease.
Topics: alpha-Synuclein; Animals; Cells, Cultured; Coculture Techniques; Dopamine; Humans; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice; Microglia; Neurons; Nitrates; Nitric Oxide; Oxidative Stress; Parkinson Disease; Peroxynitrous Acid; Tetrahydroisoquinolines | 2006 |
Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria.
Topics: Animals; Disulfides; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Glutathione; Immunoblotting; Intracellular Membranes; Liver; Mitochondria; Mitochondria, Liver; Models, Chemical; Nitric Oxide; Nitrosation; Nitroso Compounds; Oxygen Consumption; Parkinson Disease; Peroxynitrous Acid; Rats; S-Nitroso-N-Acetylpenicillamine; S-Nitrosothiols; Sepsis; Sulfhydryl Compounds; Superoxides; Time Factors | 2006 |
Cabergoline scavenges peroxynitrite enhanced by L-DOPA therapy in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Cabergoline; Chromatography, High Pressure Liquid; Ergolines; Female; Free Radical Scavengers; Humans; Levodopa; Male; Oxidative Stress; Parkinson Disease; Peroxynitrous Acid; Tyrosine | 2006 |
Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease.
Topics: Buthionine Sulfoximine; Cell Proliferation; Cells, Cultured; Dithiothreitol; Dopamine; Electron Transport Complex I; Glutamate-Cysteine Ligase; Glutathione; Humans; Mitochondria; Neurons; Nitric Oxide; Oxygen; Parkinson Disease; Peroxynitrous Acid; S-Nitrosothiols | 2006 |
Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: implications for Parkinson's disease and protection by polyphenols.
Topics: Animals; Cell Culture Techniques; Cell Survival; Cells, Cultured; Cerebral Cortex; Culture Media, Serum-Free; Dopamine; Flavonoids; Mice; Molecular Structure; Neurons; Parkinson Disease; Peroxynitrous Acid; Phenols; Polyphenols; Time Factors; Tryptamines | 2008 |
The reaction of nitric oxide with 6-hydroxydopamine: implications for Parkinson's disease.
Topics: alpha-Synuclein; Animals; Cattle; Nerve Tissue Proteins; Nitric Oxide; Oxidation-Reduction; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Peroxynitrous Acid; Serum Albumin, Bovine; Superoxide Dismutase; Synucleins; Tyrosine | 2002 |
Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide.
Topics: Animals; Cell Death; Cells, Cultured; Cytokines; Dopamine; Dose-Response Relationship, Drug; Encephalitis; Female; Interleukin-1; Lipopolysaccharides; Neurons; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Parkinson Disease; Peroxynitrous Acid; Pregnancy; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tumor Necrosis Factor-alpha | 2002 |
Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration.
Topics: Animals; Cell Count; Cell Death; Dopamine; Encephalitis; Fluorescent Dyes; Glial Fibrillary Acidic Protein; Hydroxyl Radical; Lipopolysaccharides; Macrophages; Male; NADPH Dehydrogenase; Neurons; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Parkinson Disease; Peroxynitrous Acid; Rats; Rats, Wistar; Substantia Nigra; Tyrosine 3-Monooxygenase | 2002 |